Calder Vale Peptides of Skipton closes after 8 years
A proper account of an operation that existed, and of what closing it cost.
August 2025 — Vol. 2, No. 8
Page 4 of 4 of this archive, newest first.
Also filed — page 4
the rolling newsroom, August 2025Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
SURPASS-4 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Singapore caps semaglutide prescribing to 10 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The quiet end of the online reseller trading as Adamant Research Supply
A proper account of an operation that existed, and of what closing it cost.
The United Arab Emirates pharmacy body issues counselling standards for dulaglutide initiation
The evidence base is thin and the document says so, which is to its credit.
WXT declines, for the 23rd time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Saudi Arabia declines to reimburse exenatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Calder Vale Peptides of Skipton closes after 21 years
A proper account of an operation that existed, and of what closing it cost.
The 30-day notice: how a compounding wind-down works in Switzerland
The document is four pages. Three of them are about dates.
The online reseller trading as Adamant Research Supply closes after 23 years
A proper account of an operation that existed, and of what closing it cost.
The quiet end of the relabeller trading as Vantris Bio
A proper account of an operation that existed, and of what closing it cost.
A shortage listing ends. 21 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Brazil health authority warns on falsified exenatide pens
Reported from the analysis, not from a warning notice.
SURMOUNT-1 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
What the new Ireland guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
From the floor in Hong Kong: 18 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
What a 35% rise in coupling-reagent prices does to a 30 mg vial
Follow the resin, not the catalogue.